Genfit's Loss Is Gain For Intercept Pharmaceuticals
March 27, 2015 at 13:06 PM EDT
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) faces less risk from competition for its prospective liver disease treatment after trial ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.